Gene Transfer Technologies Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034
Page: 215 | Report Code: LS250129 | Research Suite: Report (PDF) & Market Data (Excel)
Gene transfer technologies encompass a range of methods that
allow for the introduction of new genetic material into an organism's cells.
This process is crucial in both basic research and applied biology, which
enables scientists to manipulate genetic information for a variety of purposes.
MARKET
OVERVIEW
The global Gene Transfer Technologies Market is valued at approximately USD 3.63 billion in 2023 and is projected to reach USD 10.05 billion by 2034 exhibiting a compound annual growth rate (CAGR) of 9.7% during the forecast period of 2024-2034. The main objective of gene transfer is to alter the genetic composition of cells, which are essential for advancing medical therapies, enhancing agricultural productivity, facilitating scientific research, developing innovative vaccines, personalizing healthcare solutions, and addressing environmental challenges.
GROWTH
DRIVERS
The rising incidence of genetic disorders and cancers is
primarily impacting market demand. According to the World Health Organization,
20 million new cancer cases and 9.7 million deaths globally reported in 2022.
As these conditions become more prevalent, there is an increasing demand for
effective gene therapies that are capable of addressing the underlying genetic
disorders or different types of cancer. The growth of the patient population
leads to a significant demand for advanced therapeutic options, resulting in
market growth.
The growing need for improved cell and gene therapies as well as personalized medicine is one of the main factors propelling the market for gene transfer technologies. Personalized medicine aims to customize care according to each patient's unique genetic profile, which often necessitates sophisticated gene transfer techniques to modify or replace defective genes.
According to the U.S. Food and Drug Administration, around 30% of all newly
approved drugs in the U.S. are categorized as personalized medicines. The
effectiveness of these treatments is driving further investment and interest in
gene transfer technologies.
MARKET
SEGMENTATION:
By Product
-
·
Reagents, Kits & Assays
·
Consumables
·
Instruments
·
Other Products
By Mode
-
·
Viral Vectors
o Retroviruses
·
Lentiviruses
·
Other Retroviruses
o Adenoviruses
o Adeno-Associated
Viruses
o Other
Viral Vectors
·
Non-Viral Vectors
o Chemical
Methods
o Liposome-Mediated
o Calcium
Phosphate
o DEAE-Dextran
o Cationic
Polymers
o Other Chemical
Methods
·
Physical Methods
o Electroporation
o Microinjection
o Gene
Guns
o Other
Physical Methods
By Method
-
·
In-Vivo
·
Ex-Vivo
·
In-Vitro
By Application
-
·
Therapeutic Applications
o Gene
Therapy
o Cell
Therapy
o Vaccines
o Other
Therapeutic Applications
·
Research Applications
o Drug
Discovery & Development
o Infectious
Diseases
o Genetic
& Neurological Disorders
o Autoimmune
Diseases
o Other
Diseases
o Other
Research Applications
·
Other Applications
By End
User -
·
Pharmaceutical & Biotechnology
Companies
·
Academic & Research Institutes
·
Other End Users
By
Region -
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Gene
Transfer Technologies Market By Product Segment Review:
The reagents, kits & assays segment is anticipated to dominate the market in 2024 due to its critical role in research and development activities across academic and commercial laboratories. The demand for personalized medicine, to tailor treatment based on each patient’s unique need, necessitate a diverse range of reagents and kits designed for different applications in gene therapy; thus, driving market expansion.
Gene
Transfer Technologies Market By Mode Segment Review:
The expansion of the viral vectors segment in the gene
transfer technologies market is primarily driven by their effectiveness in
delivering genetic material into targeted cells. They are especially useful for
treating genetic abnormalities and chronic diseases because of their ability to
integrate into the host genome, which allows the therapeutic gene to express
itself for a longer period of time.
Gene
Transfer Technologies Market By Method Segment Review:
In 2024, in-vivo segment is expected to hold the largest
share of the gene transfer technologies market due to their direct application
in therapeutic settings. Using this technique, genetic material is delivered
directly into the cells of a living organism.
Gene
Transfer Technologies Market By Application Segment Review:
Therapeutic applications are one of the most significant
segments of the gene transfer technologies market. The therapeutic application
segment is anticipated to rise rapidly due to the growing investments in gene
therapy research and an increase in the prevalence of genetic diseases.
Gene
Transfer Technologies Market By End User Segment Review:
The market demand is increasing across pharmaceutical and
biotechnology sectors due to the increasing prevalence of genetic disorders and
the rising demand for personalized medicine, which necessitates the use of
these technologies for drug development, gene therapy, and vaccine production.
Gene
Transfer Technologies Market By Region Segment Review:
The market exhibits significant regional variations, with
North America leading the market in 2024 due to the presence of advanced
healthcare infrastructure, significant investment in research and development,
and a high concentration of key industry players.
Regional
Synopsis:
North America is anticipated to dominate the global market
for gene transfer technologies due to the robust presence of industry leaders,
supportive regulations, increasing focus on personalized medicine, and a rising
demand for innovative therapies.
The European market is growing because of its growing focus
on personalized medicine and regenerative therapies, and an increasing investment
from both public and private sectors into genetic research.
The Asia Pacific is expected to grow rapidly during the
forecast period due to their rising healthcare expenditures, improving
healthcare infrastructure, and growing awareness of genetic disorders among
population.
In Latin America, the market is gradually expanding due to increasing
investment in biotechnology sectors to address local health issues related to
genetic disorders.
The market in Middle East and Africa is witnessing growth potential due to the rising awareness of genetic therapies among citizens and increasing investments from governments aiming to improve healthcare systems in the region.
Key
Challenges:
The high cost associated with gene therapies is one of the
most major issues in this market. Access to these potentially life-saving
treatments is challenging for healthcare systems due to their costly nature,
particularly in low- and middle-income countries (LMICs).
Navigating complicated regulatory frameworks frequently
becomes challenging and time-consuming for companies that develop gene transfer
technologies. The regulations for clinical trials, product approvals, and
post-marketing surveillance vary significantly between countries. This
variation has the potential to postpone the launch of novel treatments in
different markets.
Competitive
Landscape:
The global market for gene transfer technologies market is
characterized by a diverse range of established companies, emerging startups,
and academic institutions, each striving to enhance their market presence
through various strategies such as product innovation, strategic
collaborations, regulatory compliance, diversification of offerings, global
expansion efforts, and adoption of advanced technologies.
Companies are investing significantly in research and
development (R&D) to innovate and enhance their offerings to meet the
evolving needs of various industries. This involves developing new and improved
gene delivery systems, such as viral vectors, plasmid DNA, and non-viral
methods like electroporation or lipofection. Prioritizing research and
development allow businesses to develop innovative solutions that improve
efficacy and safety profiles, which are essential for gaining market trust and
regulatory approval.
Key
Players:
·
Thermo Fisher Scientific Inc.
·
Danaher Corporation
·
Merck KGaA
·
Qiagen
·
Sartorius AG
·
Bio-Rad Laboratories Inc.
·
Revvity, Inc.
·
GenScript
·
Takara Bio Inc.
·
Promega Corporation
· Other Key & Niche Players